Invasion and metastasis are the major cause of deaths in patients with esophageal cancer. In this study, we isolated cancer stem-like cells from an esophageal squamous cell carcinoma cell line EC109 based on aldehyde dehydrogenase 1A1 (ALDH1A1), and found that ALDH1A1 high cells possessed the capacities of self-renewal, differentiation and tumor initiation, indications of stem cell properties. To support their stemness, ALDH1A1 high cells exhibited increased potential of invasion and metastasis as compared with ALDH1A1 low cells. ALDH1A1 high esophageal squamous cell carcinoma cells expressed increased levels of mRNA for vimentin, matrix metalloproteinase 2, 7 and 9 (MMP2, MMP7 and MMP9), but decreased the level of E-cadherin mRNA, suggesting that epithelial-mesenchymal transition and secretary MMPs may be attributed to the high invasive and metastatic capabilities of ALDH1A1 high cells. Furthermore, we examined esophageal squamous cell carcinoma specimens from 165 patients and found that ALDH1A1 high cells were associated with esophageal squamous dysplasia and the grades, differentiation and invasion depth, lymph node metastasis and UICC stage of esophageal squamous cell carcinoma, as well as poor prognosis of patients. Our results provide the strong evidence that ALDH1A1 high cancer stem-like cells contribute to the invasion, metastasis and poor outcome of human esophageal squamous cell carcinoma. Modern Pathology (2014) 27, 775-783; doi:10.1038/modpathol.2013.189; published online 8 November 2013
Esophageal squamous cell carcinoma is one of the most frequent fatal malignancies in the area from northern Iran to north-central China ('Asian esophageal cancer belt'). 1, 2 The 5-year survival rate of esophageal squamous cell carcinoma patients after surgery and chemotherapy remains low owing to highly invasive and metastatic nature of esophageal squamous cell carcinoma. Cancer stem-like cells are a small subpopulation within tumors with the capacities for self-renewal and generating heterogeneous tumor cell lineages. 3 Recent studies suggest that cancer stem-like cells are responsible for invasion and metastasis of many tumor types. We have reported that cancer stem-like cells possess higher capability of invasion and metastasis in solid tumors. [4] [5] [6] However, the biomarkers related to invasion and metastasis of cancer stem-like cells and the clinical significance need to be identified in esophageal squamous cell carcinoma.
Aldehyde dehydrogenase 1A1 (ALDH1A1) is a cancer stem-like cell-associated protein in various malignant tumors and its level correlates with the patient outcome. [7] [8] [9] We hypothesized that ALDH1A1 could also be used to detect and enrich cancer stemlike cells, and the level of ALDH1A1 high cells in tumor might predict the prognosis of human esophageal squamous cell carcinoma. In this study, we report that the level of ALDH1A1-expressing cells in tumor correlates with the clinic outcome of esophageal squamous cell carcinoma patients. In addition, ALDH1A1 high cells isolated from a human esophageal squamous cell carcinoma cell line exhibited properties of high invasiveness and metastasis mediated by epithelialmesenchymal transition and MMPs.
Materials and methods

Patients and Tissue Samples
Esophageal squamous cell carcinoma specimens used in this study were taken from165 cases of esophageal squamous cell carcinoma patients with written informed consent from 2006 to 2008 at Southwest Hospital. No preoperative radiotherapy or chemotherapy was used for any of the patients. All the specimens were routinely processed for pathological diagnosis according to the WHO classification. The study was approved by the Ethics Committee of the Southwest Hospital.
Immunohistochemistry
Immunohistochemical staining was performed on formalin-fixed, paraffin-embedded esophageal cancer sections (4 mm) using Dako REAL TM EnVisiont detection System (Code K5007; Dako, Glostrup, Denmark). The sections were pretreated by 0.3% H 2 O 2 and antigen retrieval was performed according to the manufacturer's instruction. The slides were incubated with mouse anti-human ALDH1A1 (Clone 44/ALDH, 1:1000; BD Bioscience, USA) at 4 1C overnight. The secondary antibody was added for incubation at 37 1C for 30 min. All slides were evaluated independently by two pathologists in a blind manner. The following points were taken as the guideline for interpreting the data: 10 the sections with 45% ALDH1A1-positive cancer cells as ALDH1A1 high and o 5% positive cells as ALDH1A1 low . Briefly, the cells with brown color in the cytoplasm were counted as positive cells. At least five fields in each section were randomly selected for calculating average percentage of positive cells over total cancer cells. For the analysis of the relationship between esophageal squamous cell carcinoma invasiveness and distribution of ALDH1A1-positive cancer cells, the ALDH1A1-positive cells within the mucosa and invading into the submucosa were counted and their percentages were calculated.
Cell Culture
The human esophageal squamous cell carcinoma cell line EC109 was purchased from Cell Bank of Shanghai Institute of Cell Biology, Chinese Academy of Sciences, and cultured in Dulbecco's modified Eagle's medium (Gibco, USA) containing 10% fetal bovine serum at 37 1C in humidified air with 5% CO 2 .
ALDEFLUOR Assay and Flow Cytometry
An ALDEFLUOR kit (Stem Cell Technologies, Canada) was used to isolate tumor cells with ALDH1A1A1 enzymatic activity according to the manufacturer's instruction. Briefly, esophageal squamous cell carcinoma cells were suspended in ALDEFLUOR assay buffer containing ALDH1A1 substrate, add BODIPYaminoacetaldehyde (BAAA) and incubated for 40 min at 37 1C. Diethylaminobenzaldehyde (DEAB), a specific ALDH1A1 inhibitor, was used as a negative control. 7-Amino-actinomycin D (7-AAD) staining solution (BD Pharmingen, USA) was used to exclude dead cells. Cells with intact plasma membrane were sorted for experiments.
Colony Formation Assay
One hundred viable esophageal squamous cell carcinoma cells per well were seeded in each well of 24-well plates and cultured in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum. After incubation for 2 weeks, colonies containing more than 50 cells were counted with crystal violet staining.
Limiting Dilution Assay
Limiting dilution assay was used to measure the frequency of cancer stem-like cells as described. 11 Briefly, six serial twofold dilutions of viable ALDH1A1A1 high and ALDH1A1 low cells were sorted into ultra-low 96-well plates (Costar, USA) with 10 wells per dilution. Sorted cells were cultured in 100 ml of serum-free Dulbecco's modified Eagle's medium/F12 medium supplemented with EGF (20 ng/ml) and bFGF (20 ng/ml) at 37 1C and 5% CO 2 . Twenty microliters of serum-free Dulbecco's modified Eagle's medium/F12 medium supplemented with EGF (20 ng/ml) and bFGF (20 ng/ml) were added to each well every 3 days. Spheres were counted at day 7.
Immunofluorescence Confocal Microscopy
For cell differentiation, FACS-sorted ALDH1A1 high cells were seeded on the cover slides and cultured in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum for 7 days. The cells were then fixed and blocked by preimmune goat serum.
Primary mouse anti-human CK18 (1:100) (Zhong Shan Jin Qiao Company, China) was added to the cells and incubated at 4 1C overnight. Secondary goat anti-mouse IgG conjugated with Cy5 (1:500) (Zhong Shan Jin Qiao Company) was added to the cells and incubated at 37 1C for 30 min. DAPI was used to stain the nuclei. Cells were then observed under laser confocal microscopy (Zeiss, Germany).
RNA Extraction and Real-Time PCR
Total RNA was extracted from tumor cells with RNAiso reagent (TakaRa, Japan). Reverse-transcription and quantitative real-time PCR were performed using an RNA PCR (AMV) kit (Fermentas, Canada) with primers designed for the following corresponding genes:
(forward) and 5 0 -TTTACATGGCACTGC CAAAGC-3 0 (reverse)); and GAPDH (NM_002046) (5 0 -AGCCACATCGCTCAGACA-3 0 (forward) and 5 0 -G CCCAATACGACCAAATCC-3 0 (reverse)). The expression of each gene by ALDH1A1 high relative to ALDH1A1 low esophageal squamous cell carcinoma cells was determined using the 2 À DDCT method. Results were normalized against GAPDH. All experiments were performed in triplicates, and results were plotted as the mean ± s.d.
Invasion Assay
Transwells (8 mm) (BD Falcon, USA) were coated with 10 ml of Matrigel TM /Dulbecco's modified Eagle's medium (1:6, v/v) for 30 min at 37 1C. ALD-H1A1 high and ALDH1A1 low esophageal squamous cell carcinoma cells were seeded into the upper Transwell chambers at the density of 5 Â 10 4 in 200 ml of serum-free Dulbecco's modified Eagle's medium. The lower chambers were filled with 500 ml of Dulbecco's modified Eagle's medium containing 10% fetal bovine serum. After 24 h incubation, filter membranes were fixed with 4% formaldehyde for 10 min. Subsequently, cells on the upper chamber were scraped by cotton swab, and the invading cells on the lower chambers were stained with crystal violet for 5 min. The invading cells were counted in five different visual areas at Â 100 magnification under an inverted microscope.
Tumorigenicity Assay
Esophageal squamous cell carcinoma cells in Matrigel TM (1:1, v/v) were injected subcutaneously into the axilla of 6-week-old nude mice with 5 Â 10 2 or 1 Â 10 2 cells per mouse (n ¼ 5). At the end of sixth week, mice were euthanized and xenograft tumors were removed and measured. Tumor volume (T V ) was calculated by the formula:
In Vivo Metastasis Assay
Intravenous injection was used to evaluate the lung metastasis ability of ALDH1A1 high and ALDH1A1 low esophageal squamous cell carcinoma cells as described. 12 Briefly, 1 Â 10 5 sorted ALDH1A1 high and ALDH1A1 low cells were injected into the tail vein of 6-week-old nude mice (n ¼ 6). All mice were killed at the sixth week and examined for tumor nodules in the lung.
Statistical Analysis
Positive staining rates were compared by using w 2 method. Rank data was analyzed by Spearman's rank correlation test. Kaplan-Meier survival plots and log-rank statistics were used to compare the survival rates of patients. All data were analyzed with SPSS13.0 statistical software. Po0.05 was considered statistically significant.
Results
ALDH1A1 high Esophageal Squamous Cell Carcinoma Cells Exhibit Cancer Stem-Like Cell Properties
We first examined the proportion of ALDH1A1 high cells contained in the esophageal squamous cell carcinoma cell line EC109, and found that ALD-H1A1 high cells accounted for 3.4%±0.5% of the whole-cell population (n ¼ 17) (Figure 1a) . The sorted ALDH1A1 high cells possessed higher capabilities of tumorsphere formation as compared with ALDH1A1 low cells (Figure 1b) . The number of colonies formed by ALDH1A1 high cells were higher than those formed by ALDH1A1 low cells (76.6%± 1.5% vs 31.3% ± 2.1%, Po0.05) (Figures 1c and d) . The ALDH1A1 high cells also showed increased expression of the stemness genes Sox2 and Bmi1 (Figure 1e ) and high differentiation potential by expressing CK18 (Figure 1f) . The tumorigenicity assay with ALDH1A1 high and ALDH1A1 low EC109 cells in nude mice showed that 1 Â 10 2 ALDH1A1 high cells initiated tumors in four of five mice (80%). All five mice (100%) grew tumors when 5 Â 10 2 ALDH1A1 high cells were implanted. In contrast, implantation of 1 Â 10 2 or 5 Â 10 2 ALDH1A1 low EC109 cells formed tumors only in one of five mice (20%) ( Table 1 ). The size of the xenograft tumors formed by ALDH1A1 high cells was much larger than those formed by ALDH1A1 low cells (Figures 1g and h (Figures 2a and b) . Moreover, the ALDH1A1 high cells formed lung metastasis in five of six mice, whereas no metastasis was formed by the ALDH1A1 low cells (Figure 2c) . Similar results were also obtained from the studies on another esophageal squamous cell carcinoma cell line TE-1 (Supplementary Figure S1) . We found that the percentage of ALDH1A1-positive cells was 8.3% in TE-1 (Supplementary Figure S1A) and sorted ALDH1A1 high TE-1 cells possessed higher capabilities of sphere formation (Supplementary Figure S1B) and colony formation as compared with ALDH1A1 low cells (72±8 vs 25±5, Po0.05) (Supplementary Figures S1C and S1D ). In addition, ALDH1A1 high TE-1 cells were found with greater invasive ability as compared with ALDH1A1 low cells (200 ± 8 vs 47 ± 6, Po0.05) ( Supplementary  Figures S1E and S1F ). Gene expression analysis further showed that ALDH1A1 high cells expressed higher levels of MMP2, MMP7, MMP9 and vimentin, and lower level of E-cadherin (Figure 2d ), indicating that their highly invasive and metastatic capabilities are associated with an epithelialmesenchymal transition phenotype. 
ALDH1A1 Expression is Correlated with Esophageal Squamous Dysplasia and Carcinoma Malignancy
For understanding the possible role of ALDH1A1 in the development and progression of human esophageal squamous cell carcinoma, we examined the expression of this protein in normal, dysplastic and cancerous esophageal epithelia. ALDH1A1 was not detected in normal esophageal epithelia, but was detectable at low levels in the dysplastic basal cells. The cytoplasmic ALDH1A1 was elevated in esophageal cells with increasing degrees of dysplasia and in carcinoma in situ (Figures 3a and b) . Sixty-seven percent (110/165 cases) of esophageal squamous cell carcinoma samples were ALDH1A1 high in primary tumors ( Table 2 ). The expression of ALDH1A1 was positively correlated with histological grades (P ¼ 0.004), invasion depth (P ¼ 0.000), lymph node metastasis (P ¼ 0.002) and UICC staging (P ¼ 0.000) of esophageal squamous cell carcinoma (Table 2 , Figure 3c ). To reveal the relationship of ALDH1A1 expression cells to cancer cell invasiveness, we quantitatively analyzed ALDH1A1-positive cells in the tumor tissues of T1 stage esophageal squamous cell carcinoma. The percentage of ALDH1A1-positive cancer cells was significantly higher in tumor tissues invading submucosa than tumor tissues within the mucosa (83%±6% vs 13%±12%, Esophageal cancer stem-like cells Po0.05; Figure 3d ). These results indicate that ALDH1A1 expression is correlated with the development and progression of esophageal squamous cell carcinoma.
High ALDH1A1 Expression is Correlated with Poor Patient Prognosis
We then analyzed the relationship between ALD-H1A1 expression and the survival of a total 134 esophageal squamous cell carcinoma patients with follow-up data. Median survival time of the total patients was 31 months (ranging from 1 to more than 75 months). Kaplan-Meier survival curves showed that the 5-year survival rates for patients with ALDH1A1 low tumors were 46%, but 23% for patients with ALDH1A1 high tumors (Figure 4a , P ¼ 0.008). Patients with ALDH1A1 low tumors at early stages (IA þ IB) (Figure 4b , P ¼ 0.02) or with well-differentiated esophageal squamous cell carcinoma (G1) (Figure 4c , P ¼ 0.021) had longer lifespan than those with ALDH1A1 high tumors. However, the survival rate of patients with later stage (II and III) (P40.05) or moderately and poorly differentiated esophageal squamous cell carcinoma (G2 and 3) (P40.05) were similar, regardless of ALDH1A1po-sitivity. Thus, ALDH1A1 predicts esophageal squamous cell carcinoma outcome and can be used as a biomarker for patient prognosis.
Discussion
In this study, we revealed for the first time that ALDH1A1 high esophageal squamous cell carcinoma cells possess cancer stem cell property and that the expression of ALDH1A1 is associated with esophageal squamous dysplasia and carcinoma. Esophageal squamous dysplasia, a precancerous lesion of esophageal squamous cell carcinoma, refers to abnormal morphological changes of squamous cells. Thus, ALDH1A1-expressing cells have a crucial role in the initiation and progression of esophageal squamous cell carcinoma. ALDH1A1 is a predominant isoform of aldehyde dehydrogenase family in mammals located in the cytoplasm 15, 16 and is originally considered as a marker for normal hematopoietic progenitor cells, 17 and is also found in cancer cells with stem cell property, that is, cancer stem-like cells, in several malignant tumors including leukemia, 9 breast cancer 7 and lung cancer. 8, 18 Wang et al 19 reported that ALDH1A1 was located in the nuclei of esophageal squamous cell carcinoma cells. However, we detected that ALDH1A1 protein mainly in the cytoplasm of precancerous and cancer cells of esophagus, consistent with reports on breast and ovarian tumors. 7, 20 Our data showed that in the low-grade esophageal squamous dysplasia, ALDH1A1-positive cells were distributed in the basal layer of the mucosa, suggesting normal mucosal stem cells as one of the sources for cancer stem-like cells. 21 Further, ALDH1A1 expression was positively correlated with the UICC stages, invasion depth and lymph node metastasis of esophageal squamous cell carcinoma and was associated with shorter survival of the patients. Therefore, ALDH1A1-expressing cells are crucial for the development and progression of esophageal squamous cell carcinoma and ALDH1A1 may be used as a biomarker for malignancy of esophageal squamous cell carcinoma and a predictor of patient prognosis.
It is important to note that ALDH1A1 high cells possess the property of cancer stem-like cells in esophageal squamous cell carcinoma. It has been reported that esophageal cancer stem-like cells may reside in a side population of cancer cells. [22] [23] [24] However, Zhao et al25 found no correlation between the presence of side population of cancer cells and the tumorigenicity of the esophageal squamous cell carcinoma cells. CD44 has also been proposed as a marker for cancer stem-like cells in esophageal squamous cell carcinoma, although most of the esophageal squamous cell carcinoma cells express CD44. 25, 26 Another molecule, CD90 as a cancer stem-like cell marker of esophageal squamous cell carcinoma cells, remains debatable. 25, 27 Tumorsphere culture and pretreatment with radiation may be used for enrichment of cancer stem-like cells from esophageal squamous cell carcinoma; however, the cell heterogeneity limits Cancer stem-like cells are involved in the invasion and metastasis with yet to be defined mechanisms. We found that ALDH1A1-positive cells were preferentially distributed in the invasion frontier of esophageal squamous cell carcinoma and metastatic lesions. Our in vitro results also demonstrated that ALDH1A1 high esophageal squamous cell carcinoma cells were more highly invasive and metastatic. ALDH1A1 high cancer stem-like cells also express high levels of vimentin but low levels of E-cadherin, indicating an epithelial-mesenchymal transition phenotype of ALDH1A1 high cancer stem-like cells. 32 MMP family members are capable of degrading extracellular matrix proteins and pave a path for cancer cell migration and invasion. 33 Thus, ALDH1A1 high cancer stem-like cells, by expressing high levels of MMPs and exhibiting an epithelialmesenchymal transition phenotype, contribute to the invasion and metastasis of esophageal squamous cell carcinoma. In summary, we provide the strong evidence that ALDH1A1 high cancer stem-like cells contribute to the invasion, metastasis and poor outcome of human esophageal squamous cell carcinoma. 
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